Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038023
Filing Date
2023-08-03
Accepted
2023-08-03 16:17:56
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20230630.htm   iXBRL 10-Q 2711283
2 EX-10.1 alec-ex10_1.htm EX-10.1 16847
3 EX-31.1 alec-ex31_1.htm EX-31.1 29564
4 EX-31.2 alec-ex31_2.htm EX-31.2 29561
5 EX-32.1 alec-ex32_1.htm EX-32.1 11192
6 EX-32.2 alec-ex32_2.htm EX-32.2 11239
7 GRAPHIC img142868347_0.jpg GRAPHIC 27251
  Complete submission text file 0000950170-23-038023.txt   7640353

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alec-20230630_def.xml EX-101.DEF 129518
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20230630_lab.xml EX-101.LAB 332216
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20230630_pre.xml EX-101.PRE 230800
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alec-20230630_cal.xml EX-101.CAL 36525
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20230630.xsd EX-101.SCH 33973
49 EXTRACTED XBRL INSTANCE DOCUMENT alec-20230630_htm.xml XML 1244821
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 231140319
SIC: 2836 Biological Products, (No Diagnostic Substances)